Patients with hepatic steatosis had lower OPG concentrations than those without liver involvement, although they did not reach statistical significance.
← all excerpts
Role of osteoprotegerin/receptor activator of nuclear factor kappa B/receptor activator of nuclear factor kappa B ligand axis in nonalcoholic fatty liver disease.
1
—
—